J Retin.  2022 May;7(1):54-58. 10.21561/jor.2022.7.1.54.

Multifocal Retinal and Ciliary Artery Occlusion with Submacular Hemorrhage Following Cosmetic Facial Filler Injection

Affiliations
  • 1Department of Ophthalmology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Abstract

Purpose
Retinal artery occlusion and ciliary artery occlusion (CAO) may occur as complications after cosmetic filler injections. However, submacular and subhyaloid hemorrhage have not been reported after cosmetic filler injection. Herein, we report the first case of subretinal hemorrhage after iatrogenic multifocal retinal and CAO following facial filler injection.
Case summary
A 44-year-old woman with no relevant medical history presented with a sudden upper visual field defect of the right eye immediately after receiving hyaluronic acid cosmetic facial filler injection in the glabellar region. The patient was diagnosed with multiple branch retinal and posterior CAO of the right eye. On the fourth day of follow-up, submacular and subhyaloid hemorrhage was observed. Intravitreal injection of 1.25 mg bevacizumab and 0.2 mL pure C 3 F 3(octafluoropropane) gas was performed. At the 2-month follow-up, subretinal and subhyaloid hemorrhage at the macula had resolved. Without further treatment, the retina was stable with no further recurrence through the 1-year follow-up.
Conclusions
Submacular and subhyaloid hemorrhage following branch retinal and posterior CAO immediately after cosmetic facial filler injection is a rare, but serious complication. Although the pathogenic mechanism for subretinal hemorrhage remains unclear, bevaci- zumab injection combined with 0.2 mL pure C 3F 3 gas injection may be a possible treatment option when faced with such complications.

Keyword

Cosmetic filler injection; Retinal artery occlusion; Subhyaloid hemorrhage; Submacular hemorrhage; Subretinal hemorrhage
Full Text Links
  • JR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr